Pharmacy
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.
The FDA is looking at additional data on a booster dose in children 6 months to 4 years old.
Since 2014, drug prices have increased 35%, while the cost of all items and services has increased 19%.
AHIP agreed that more clinical-trial-based evidence is needed on Aduhelm's benefits and the potential risks to patients.
The Eli Lilly drug awaits emergency use authorization from the FDA.
SD Biosensor said it has initiated an investigation to determine how the product was illegally imported into the U.S.
The money is going to eight community organizations serving underserved areas to boost vaccine confidence.
Legislation could permit insurers to base payment for COVID-19 tests administered out-of-network on their median in-network rate, AHIP says.
Meanwhile, 29% of such parents said they'll take a wait-and-see approach, while 12% said they'd do it only if it was required.
The tests are expected to become available in early spring for those on original Medicare or in a Medicare Advantage plan.